First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy

OBJECTIVE: This study aimed to directly compare the effectiveness of first‐line monotherapy levetiracetam (LEV) versus enzyme‐inducing antiseizure medications (EIASMs) in glioma patients. METHODS: In this nationwide retrospective observational cohort study, Grade 2–4 glioma patients were included, w...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Meer, Pim B., Maschio, Marta, Dirven, Linda, Taphoorn, Martin J. B., Koekkoek, Johan A. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100008/
https://www.ncbi.nlm.nih.gov/pubmed/36380710
http://dx.doi.org/10.1111/epi.17464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100008/
https://www.ncbi.nlm.nih.gov/pubmed/36380710
http://dx.doi.org/10.1111/epi.17464

Ejemplares similares